AssayIndex
Reports by quarter

Reports submitted in 2025-Q4 · page 18

Provenance classification became a required field. Median purity for the quarter is 99.12 % area, n=762. Read the 2025-Q4 state-of-the-index report →

762 records20 pagesmedian on this page 99.19 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019037BPC-157ASYASY-{CAT}-2719Nordanalyt2025-Q499.795.17—Buyer-sourced0PASS
AX-2025-019035KPVASYASY-{CAT}-2158Kestrel2025-Q499.833.32—Buyer-sourced0FAIL
AX-2025-018935BPC-157TFSTFS-{CAT}-1157Janoshik2025-Q499.815.92101.6Buyer-sourced0PASS
AX-2025-018800SemaglutideFGPFGP-2506-J7851PeptideMeter2025-Q499.934.7596.8Buyer-sourced1MARGINAL
AX-2025-021140VilonSIGSIG-2505-6919VendorInvestigate2025-Q498.177.72—Buyer-sourced0FAIL
AX-2025-021090CagrilintideBCHBCH-2509-A4594Janoshik2025-Q499.206.5496.7Buyer-sourced0PASS
AX-2025-020809GHRP-6CPCCPC-2507-G1030Janoshik2025-Q499.936.50103.6Buyer-sourced0PASS
AX-2025-020754TirzepatideSGNSGN-2505-G9079PeptideMeter2025-Q498.494.68—Buyer-sourced0PASS
AX-2025-020468TirzepatideKPKP-2506-B5255PeptideMeter2025-Q497.963.66—Supplier-supplied0PASS
AX-2025-020277LiraglutideGGPepsGGPE-2505-W2368Medutest2025-Q499.787.47—Supplier-supplied2MARGINAL
AX-2025-020124IpamorelinERPERP-2505-U8938Janoshik2025-Q499.643.75—Buyer-sourced2MARGINAL
AX-2025-019277GHRP-6AMBAMB-2506-D5337Nordanalyt2025-Q499.363.1588.9Buyer-sourced1MARGINAL
AX-2025-018529BPC-157QYBQYB-2506-B4259Nordanalyt2025-Q499.675.3193.1Laboratory-retained0PASS
AX-2025-018459TirzepatideWWBWWB-2506-T2732PeptideMeter2025-Q499.103.44—Buyer-sourced0PASS
AX-2025-020995SemaglutideWXTWXT-2507-N3348Medutest2025-Q497.065.1096.0Buyer-sourced0PASS
AX-2025-020193TB-500ERPERP-2509-K9340Medutest2025-Q499.192.90101.6Buyer-sourced0PASS
AX-2025-019133AOD-9604GSPGSP-2505-S3921VendorInvestigate2025-Q498.564.0192.1Buyer-sourced0PASS
AX-2025-019131AOD-9604GSPGSP-2505-S3921VendorInvestigate2025-Q498.702.96103.8Buyer-sourced0PASS
AX-2025-019021PramlintideASYASY-{CAT}-2288Nordanalyt2025-Q498.525.26—Buyer-sourced0PASS
AX-2025-018801TB-500FGPFGP-2508-S8145Janoshik2025-Q499.853.1788.6Buyer-sourced1MARGINAL
AX-2025-018531ARA-290QYBQYB-2511-Y4275VendorInvestigate2025-Q499.665.74—Buyer-sourced0PASS
AX-2025-020284LiraglutideGGPepsGGPE-2505-W2368Medutest2025-Q498.807.51—Buyer-sourced1MARGINAL
AX-2025-019743Melanotan IIHomopeptideHOMO-2505-N4086Nordanalyt2025-Q499.022.56100.3Buyer-sourced0PASS
AX-2025-019285SemaglutideAMBAMB-2510-H5619PeptideMeter2025-Q498.845.56107.3Buyer-sourced1MARGINAL
AX-2025-018755TirzepatideQSCQSC-2510-D7439Janoshik2025-Q498.833.75107.4Buyer-sourced1MARGINAL
AX-2025-021227GHRP-6PPGPPG-2510-A7678Kestrel2025-Q499.933.62—Buyer-sourced0PASS
AX-2025-020353GHRP-2MKMMKM-2506-K3642Janoshik2025-Q499.484.41—Buyer-sourced0PASS
AX-2025-020281LiraglutideGGPepsGGPE-2505-W2368Janoshik2025-Q498.656.9894.6Buyer-sourced1MARGINAL
AX-2025-019967IpamorelinHJHJ-2511-D7081PeptideMeter2025-Q499.403.5589.4Laboratory-retained1MARGINAL
AX-2025-018936BPC-157TFSTFS-{CAT}-1157Kestrel2025-Q499.935.37—Buyer-sourced0PASS
AX-2025-018479CJC-1295 with DACWWBWWB-2509-J2816Janoshik2025-Q499.153.22—Buyer-sourced0PASS
AX-2025-020956SemaglutideWXTWXT-2505-P3150Nordanalyt2025-Q499.935.31—Supplier-supplied0PASS
AX-2025-020209BPC-157GGPepsGGPE-2509-N9693Janoshik2025-Q498.764.6695.8Buyer-sourced0PASS
AX-2025-020178CJC-1295 (no DAC)ERPERP-2506-B9718VendorInvestigate2025-Q498.765.65—Buyer-sourced0PASS
AX-2025-019680SemaxTFCTFC-2505-H2637Janoshik2025-Q499.648.3191.1Buyer-sourced0PASS
AX-2025-019640SelankTFCTFC-2511-C2146Janoshik2025-Q499.567.90—Buyer-sourced2FAIL
AX-2025-018550RetatrutideQYBQYB-2507-R4727Nordanalyt2025-Q498.493.8589.7Buyer-sourced1MARGINAL
AX-2025-020819PemvidutideCPCCPC-2507-H1165PeptideMeter2025-Q497.903.89101.6Supplier-supplied0PASS
AX-2025-020479KPVKPKP-2509-N5703PeptideMeter2025-Q499.192.4491.7Buyer-sourced0FAIL
AX-2025-020386PT-141 (Bremelanotide)MKMMKM-2509-B4043Janoshik2025-Q499.215.6199.2Buyer-sourced1MARGINAL